The Eveready East Africa Board of Directors has appointed little known Thomas Mong’are Masaki as the new Acting Managing Director.
This decision has been made pending the appointment of a substantive Managing Director by the listed firm’s board.
Thomas takes over from Margaret A Odhiambo, who has been performing as Acting MD since February 1st, 2019.
Eveready East Africa strategic plan
The company has successfully implemented phase one of the recovery strategy under the 2018/22 blueprint under her. The firm has thus seen improvement in its bottom line and growth. Odhiambo is a member of the Institute of Directors (Kenya) and Law Society of Kenya. In the past, she was Senior Associate at Anjarwalla & Khanna Advocates.
She received a graduate degree from the University of Nairobi and an MBA from Strathmore Business School.
A change in the firm’s executive suite occurs when Eveready has been given more time to publish its 2020 end year results.
The board has sought time to consider the impact of COVID-19 on the business for the year ended 31st September 2020.
Eveready East Africa Limited manufactures and markets a range of portable power products in Kenya and exports products to countries in the East Africa sub-region.
Its extensive product range includes:
- Dry cell and carbon-zinc primary, alkaline and rechargeable batteries.
- Flashlights and portable lanterns.
- Automotive batteries and CFL and incandescent bulbs sold under the Turbo brand name.
Eveready also supplies batteries and accessories for motor vehicles and trucks. It sells a range of washing detergents, household bleaches, surface cleaners and fabric softeners under the Clorox and Everclean brands.
Formerly known as Eveready East Africa Limited, the company changed its name to Eveready East Africa Plc some five years ago.
According to unaudited results posted on the firm’s website, for the six months ended 31st March 2020, the Group made a pre-tax loss of KSh 14 Million compared to a pre-tax loss of KSh 38.7 Million the prior year.
ALSO READ: Eveready Delays Publication of its End-Year Results on Pandemic Woes
